TY - JOUR A2 - Gronchi，亚历山德罗AU - Gholami，Sepideh AU - 雅各布，夏洛特D. AU - 卡普，丹尼尔·S·AU - Parast，莱拉M. AU - 诺顿，杰弗里A. PY - 2009 DA - 2009/10 /08 TI - 605840 VL - - 2009 AB外科腹膜后肉瘤SP的价值 - 介绍。腹膜后肉瘤是罕见的大恶性肿瘤。 方法。四十一连续的患者的局部腹膜后肉瘤进行回顾性研究。 结果。平均年龄为58岁（20-91岁）。Median tumor size was 17.5 cm (range 4–41 cm). Only 2 tumors were <5 cm. Most were liposarcoma (44%) and high-grade (59%). 59% were stage 3 and the rest was stage 1. Median followup was 10 months (range 1–106 months). Thirty-eight patients had an initial complete resection; 15 (37%) developed recurrent sarcoma and 12 (80%) had a second complete resection. Patients with an initial complete resection had a 5-year survival of 46%. For all patients, tumor grade affected overall survival ( P = 0.006 ）。手术完全切除改善了高级别肿瘤总生存期（ P = 0.03 ）。 结论。肿瘤的分级/分期和手术完全切除高档肿瘤预后的重要变量。放射治疗或化疗对总体或无复发生存率无显著影响。手术完全切除是首选治疗初始和局部复发的腹膜后肉瘤的治疗。SN - 1357-714X UR - https://doi.org/10.1155/2009/605840 DO - 10.1155 /六十〇万五千八百四十〇分之二千零九JF - 肉瘤PB - Hindawi出版公司公司KW - ER -